LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp., (NASDAQ: SNTA) announced that Anthony Williams, M.D., Vice President, Clinical Research, Synta will present new clinical data on STA-4783 in combination with paclitaxel compared to paclitaxel alone in the treatment of metastatic melanoma at the European Conference on Clinical Oncology (ECCO) on September 26, 2007 in Barcelona, Spain. The presentation will also be featured in an ECCO press briefing at 11:00 AM local time on the same day.
